Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Deficiency of factor-inhibiting HIF creates a tumor-promoting immune microenvironment

Journal article

Ma J. et al, (2024), Proceedings of the National Academy of Sciences, 121

p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer

Journal article

Miller P. et al, (2023), Cell Death & Differentiation, 30, 1619 - 1635

Regulation of immunological tolerance by the p53-inhibitor iASPP

Journal article

Akama-Garren EH. et al, (2023), Cell Death & Disease, 14

Cell autonomous role of iASPP deficiency in causing cardiocutaneous disorders

Journal article

Dedeić Z. et al, (2018), Cell Death & Differentiation, 25, 1289 - 1303

ASPP2 deficiency causes features of 1q41q42 microdeletion syndrome

Journal article

Zak J. et al, (2016), Cell Death & Differentiation, 23, 1973 - 1984

Phosphorylation of Ser312 contributes to tumor suppression by p53 in vivo

Journal article

Slee EA. et al, (2010), Proceedings of the National Academy of Sciences, 107, 19479 - 19484

A complex barcode underlies the heterogeneous response of p53 to stress

Journal article

Murray-Zmijewski F. et al, (2008), Nature Reviews Molecular Cell Biology, 9, 702 - 712

ASPP2: A Gene that Controls Life and Death in Vivo

Journal article

Vives V. et al, (2006), Cell Cycle, 5, 2187 - 2190

To die or not to die: how does p53 decide?

Journal article

Slee EA. et al, (2004), Oncogene, 23, 2809 - 2818

Load More